Home Parenteral Nutrition in Cancer Patients
This study is being done to examine the effect of Parenteral (intravenous) nutrition support in the home setting on quality of life in cancer patients. In addition, this study is being done to examine the effect of home parenteral nutrition on the use of pain and anti-nausea medication.
Cancer
DIETARY_SUPPLEMENT: Home Parenteral Nutrition
Quality of Life, To examine the effect of parenteral nutrition support in the home care setting on quality of life as measured by the EORTC QLQ-C30, Monthly for a minimum of 3 months to a maximum of 12 months
Pain and nausea medication usage, To examine the effect of home parenteral nutrition on the use of pain medication and anti-emetic therapy administered intravenously, subcutaneously, or orally., Monthly for a minumum of 3 months to a maximum of 12 months
This is a prospective descriptive non-randomized clinical study to examine quality of life outcomes and use of pain and anti-emetic therapy for patients receiving HPN support. The EORTC QLQ-C30 will be used to evaluate quality of life. All subjects will be monitored monthly throughout the course of treatment for a minimum of 3 months and a maximum of 1 year.